Ectopic Colonization and Immune Landscapes of Periodontitis Microbiota in Germ-Free Mice With Streptozotocin-Induced Type 1 Diabetes Mellitus

A two-way relationship between diabetes and periodontitis has been discussed recently. Periodontitis microbiota might affect the immune homeostasis of diabetes, but the molecular mechanism of their interactions is still not clear. The aims of this study were to clarify the possible immune regulatory effects of periodontitis microbiota on diabetes and the correlation between immunomodulation and ectopic colonization. A model of germ-free mice with streptozotocin-induced type 1 diabetes mellitus (T1D), which was orally inoculated with mixed saliva samples for 2 weeks, was used in this study. Those mice were randomly divided into two groups, namely, SP (where the T1D mice were orally inoculated with mixed saliva samples from periodontitis patients) and SH (where the T1D mice were orally inoculated with mixed saliva samples from healthy subjects). Ectopic colonization of saliva microbiota was assessed using culture-dependent method and Sanger sequencing, and the composition of gut microbiota was analyzed using 16S rRNA gene sequencing. Changes in 15 types of immune cells and six cytokines either from the small intestine or spleen were detected by multicolor flow cytometry. The correlation between gut microbiota and immune cells was evaluated by redundancy analysis. Although periodontitis microbiota minorly colonized the lungs, spleens, and blood system, they predominantly colonized the gut, which was mainly invaded by Klebsiella. SH and SP differed in beta diversity of the gut bacterial community. Compared to SH, microbial alteration in small intestine occurred with an increase of Lacticaseibacillus, Bacillus, Agathobacter, Bacteroides, and a decrease of Raoultella in SP. More types of immune cells were disordered in the spleen than in the small intestine by periodontitis microbiota, mainly with a dramatical increase in the proportion of macrophages, plasmacytoid dendritic cells (pDCs), monocytes, group 3 innate lymphoid cells, CD4-CD8- T cells and Th17 cells, as well as a decline of αβT cells in SP. Cytokines of IFNγ, IL17, and IL22 produced by CD4 + T cells as well as IL22 produced by ILCs of small intestine rose in numbers, and the intestinal and splenic pDCs were positively regulated by gut bacterial community in SP. In conclusion, periodontitis microbiota invasion leads to ectopic colonization of the extra-oral sites and immune cells infiltration, which might cause local or systemic inflammation. Those cells are considered to act as a “bridge” between T1D and periodontitis.

[1]  Jie Pan,et al.  ILC1s and ILC3s Exhibit Inflammatory Phenotype in Periodontal Ligament of Periodontitis Patients , 2021, Frontiers in Immunology.

[2]  D. Cui,et al.  Role of Th22 Cells in the Pathogenesis of Autoimmune Diseases , 2021, Frontiers in Immunology.

[3]  Craig S. Miller,et al.  Salivary Biomarkers For Discriminating Periodontitis in the Presence of Diabetes. , 2020, Journal of clinical periodontology.

[4]  S. Sethi,et al.  Oral-lung microbiome interactions in lung diseases. , 2020, Periodontology 2000.

[5]  Y. Qi,et al.  Another evidence of the Oral-Lung Axis: oral health as a determinant of lung health. , 2020, Oral diseases.

[6]  T. Greiling,et al.  Host–microbiota interactions in immune-mediated diseases , 2020, Nature Reviews Microbiology.

[7]  M. Pepper,et al.  In Vivo CD4+ T Cell Differentiation and Function: Revisiting the Th1/Th2 Paradigm. , 2020, Annual review of immunology.

[8]  P. Bittner-Eddy,et al.  Transient Expression of IL-17A in Foxp3 Fate-Tracked Cells in Porphyromonas gingivalis-Mediated Oral Dysbiosis , 2020, Frontiers in Immunology.

[9]  B. Momeni,et al.  The Role of Gut Microbiota and Environmental Factors in Type 1 Diabetes Pathogenesis , 2020, Frontiers in Endocrinology.

[10]  N. Lanthier,et al.  Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients , 2020, Gut.

[11]  N. Pandis,et al.  Clinical and microbial oral health status in children and adolescents with type 1 diabetes mellitus. , 2019, International dental journal.

[12]  C. Jobin,et al.  Microbiota in pancreatic health and disease: the next frontier in microbiome research , 2019, Nature Reviews Gastroenterology & Hepatology.

[13]  H. Siljander,et al.  Microbiome and type 1 diabetes , 2019, EBioMedicine.

[14]  O. Cinek,et al.  Human gut microbiota transferred to germ-free NOD mice modulate the progression towards type 1 diabetes regardless of the pace of beta cell function loss in the donor , 2019, Diabetologia.

[15]  M. Hattori,et al.  Influence of Porphyromonas gingivalis in gut microbiota of streptozotocin-induced diabetic mice. , 2019, Oral diseases.

[16]  Boning Zeng,et al.  ILC3 function as a double-edged sword in inflammatory bowel diseases , 2019, Cell Death & Disease.

[17]  Xuedong Zhou,et al.  Oral bacteria colonize and compete with gut microbiota in gnotobiotic mice , 2019, International Journal of Oral Science.

[18]  Luis Pedro Coelho,et al.  Extensive transmission of microbes along the gastrointestinal tract , 2018, bioRxiv.

[19]  D. Graves,et al.  The Oral Microbiota Is Modified by Systemic Diseases , 2018, Journal of dental research.

[20]  P. van Endert,et al.  Gut Microbiota-Stimulated Innate Lymphoid Cells Support β-Defensin 14 Expression in Pancreatic Endocrine Cells, Preventing Autoimmune Diabetes. , 2018, Cell metabolism.

[21]  久 久野.  Oral bacteria ノックアウト , 2018 .

[22]  W. Borgnakke,et al.  Periodontal complications of hyperglycemia/diabetes mellitus: Epidemiologic complexity and clinical challenge , 2018, Periodontology 2000.

[23]  Yuanlin Ding,et al.  Trehalose prevents sciatic nerve damage to and apoptosis of Schwann cells of streptozotocin-induced diabetic C57BL/6J mice. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[24]  R. Vernal,et al.  Alveolar bone resorption and Th1/Th17‐associated immune response triggered during Aggregatibacter actinomycetemcomitans‐induced experimental periodontitis are serotype‐dependent , 2018, Journal of periodontology.

[25]  A. Fodor,et al.  Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models , 2018, Carcinogenesis.

[26]  P. Kubes,et al.  Immune Responses in the Liver. , 2018, Annual review of immunology.

[27]  C. Hedrich,et al.  TCRαβ+CD3+CD4-CD8- (double negative) T cells in autoimmunity. , 2018, Autoimmunity reviews.

[28]  Yulong Yin,et al.  Gut Microbiota and Type 1 Diabetes , 2018, International journal of molecular sciences.

[29]  J. López‐López,et al.  Benefits of non‐surgical periodontal treatment in patients with type 2 diabetes mellitus and chronic periodontitis: A randomized controlled trial , 2018, Journal of clinical periodontology.

[30]  S. Sozzani,et al.  Dendritic cell recruitment and activation in autoimmunity. , 2017, Journal of autoimmunity.

[31]  Evan Bolton,et al.  Database resources of the National Center for Biotechnology Information , 2017, Nucleic Acids Res..

[32]  R. Jalan,et al.  Targeting the gut-liver axis in liver disease. , 2017, Journal of hepatology.

[33]  Zhili He,et al.  Biodiversity and species competition regulate the resilience of microbial biofilm community , 2017, Molecular ecology.

[34]  J. Segre,et al.  Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation , 2017, Science.

[35]  E. Bonifacio,et al.  Type 1 diabetes mellitus , 2017, Nature Reviews Disease Primers.

[36]  Ching-mei Hsu,et al.  Lactobacillus salivarius reverse diabetes-induced intestinal defense impairment in mice through non-defensin protein. , 2016, The Journal of nutritional biochemistry.

[37]  Eric G. Pamer,et al.  Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδT cells , 2016, Nature Medicine.

[38]  A. La Cava,et al.  Adaptive immune regulation in autoimmune diabetes. , 2016, Autoimmunity reviews.

[39]  R. Burcelin,et al.  Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response , 2016, Gut.

[40]  M. V. Herrath,et al.  CD4 T cell differentiation in type 1 diabetes , 2016, Clinical and experimental immunology.

[41]  E. Gianchecchi,et al.  Gene/environment interactions in the pathogenesis of autoimmunity: new insights on the role of Toll-like receptors. , 2015, Autoimmunity reviews.

[42]  B. Furman,et al.  Streptozotocin‐Induced Diabetic Models in Mice and Rats , 2015, Current protocols in pharmacology.

[43]  Huijue Jia,et al.  The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment , 2015, Nature Medicine.

[44]  Tao Wu,et al.  Alteration of Mevalonate Pathway in Proliferated Vascular Smooth Muscle from Diabetic Mice: Possible Role in High-Glucose-Induced Atherogenic Process , 2015, Journal of diabetes research.

[45]  R. Wirth,et al.  Regionally Distinct Alterations in the Composition of the Gut Microbiota in Rats with Streptozotocin-Induced Diabetes , 2014, PloS one.

[46]  L. Szablewski.  Role of immune system in type 1 diabetes mellitus pathogenesis. , 2014, International immunopharmacology.

[47]  M. Atkinson,et al.  Increased IFN-α–Producing Plasmacytoid Dendritic Cells (pDCs) in Human Th1-Mediated Type 1 Diabetes: pDCs Augment Th1 Responses through IFN-α Production , 2014, The Journal of Immunology.

[48]  Antonio Grieco,et al.  The Liver May Act as a Firewall Mediating Mutualism Between the Host and Its Gut Commensal Microbiota , 2014, Science Translational Medicine.

[49]  Tao Yang,et al.  Increased Th22 cells are independently associated with Th17 cells in type 1 diabetes , 2014, Endocrine.

[50]  Se Jin Song,et al.  The treatment-naive microbiome in new-onset Crohn's disease. , 2014, Cell host & microbe.

[51]  L. Bradley,et al.  Islet Antigen-Specific Th17 Cells Can Induce TNF-α–Dependent Autoimmune Diabetes , 2014, The Journal of Immunology.

[52]  O. Vaarala.  Human Intestinal Microbiota and Type 1 Diabetes , 2013, Current Diabetes Reports.

[53]  Pelin Yilmaz,et al.  The SILVA ribosomal RNA gene database project: improved data processing and web-based tools , 2012, Nucleic Acids Res..

[54]  Xuefeng Yu,et al.  Th17 cells in type 1 diabetes. , 2012, Cellular immunology.

[55]  P. Marchetti,et al.  Peripheral and Islet Interleukin-17 Pathway Activation Characterizes Human Autoimmune Diabetes and Promotes Cytokine-Mediated β-Cell Death , 2011, Diabetes.

[56]  S. Grey,et al.  B cell-directed therapies in type 1 diabetes. , 2011, Trends in immunology.

[57]  G. Chabot-Roy,et al.  Implication of the CD47 pathway in autoimmune diabetes. , 2010, Journal of autoimmunity.

[58]  A. Cooke,et al.  Immune cell crosstalk in type 1 diabetes , 2010, Nature Reviews Immunology.

[59]  Donald C. Comeau,et al.  Database resources of the National Center for Biotechnology Information , 2009, Nucleic Acids Res..

[60]  G. Tsokos,et al.  Human TCR-αβ+ CD4− CD8− T Cells Can Derive from CD8+ T Cells and Display an Inflammatory Effector Phenotype1 , 2009, The Journal of Immunology.

[61]  J. Watson,et al.  Fas-Mediated Apoptosis Regulates the Composition of Peripheral αβ T Cell Repertoire by Constitutively Purging Out Double Negative T Cells , 2008, PloS one.

[62]  J. Neu,et al.  The “Perfect Storm” for Type 1 Diabetes , 2008, Diabetes.

[63]  A. Flyvbjerg,et al.  Relationship between periodontitis and diabetes: lessons from rodent studies. , 2007, Journal of periodontology.

[64]  J. Bluestone,et al.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. , 2000, Immunity.

[65]  Laura Marshall,et al.  Type 1 diabetes mellitus , 2017, Nature Reviews Disease Primers.

[66]  Nicole B Arweiler,et al.  The Oral Microbiota. , 2016, Advances in experimental medicine and biology.

[67]  Roy Kennedy,et al.  Application of redundancy analysis for aerobiological data , 2014, International Journal of Biometeorology.

[68]  Jennifer C. Drew,et al.  Toward defining the autoimmune microbiome for type 1 diabetes , 2011, The ISME Journal.

[69]  B. Hosseini,et al.  Transient Expression of , 2011 .

[70]  A. Cooke,et al.  Type 1 diabetes development requires both CD4+ and CD8+ T cells and can be reversed by non-depleting antibodies targeting both T cell populations. , 2009, The review of diabetic studies : RDS.

[71]  J. Richie,et al.  Staging and Grading , 2003 .

[72]  N. Martin,et al.  Gene–Environment Interactions , 2002 .